Related Experiment Video
Updated: Jul 3, 2026
10:10
HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
HOX expression patterns identify a common signature for favorable AML
M Andreeff1, V Ruvolo, S Gadgil
1Department of Stem Cell Transplantation, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leukemia
|August 1, 2008
Summary
Deregulated HOX gene expression is linked to acute myeloid leukemia (AML) subtypes. Specific HOX expression patterns can predict AML prognosis and identify distinct patient groups, aiding in disease understanding.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Aberrant HOX gene expression, often due to chromosomal translocations and MLL rearrangements, is implicated in leukemia development.
- Understanding HOX gene expression patterns in acute myeloid leukemia (AML) is crucial for classifying disease subtypes and predicting outcomes.
Purpose of the Study:
- To investigate the expression of HOX, polycomb, MLL, and FLT3 genes in adult acute myeloid leukemia (AML) patients.
- To correlate HOX gene expression patterns with cytogenetic groups, mutations, and patient survival.
- To develop a gene expression-based predictor for AML classification.
Main Methods:
- Real-time reverse transcription-PCR was used to analyze the expression of 43 genes in 119 newly diagnosed adult AML samples.
- A 17-gene predictor model was developed and tested on 44 additional samples.
- Gene expression levels were compared across different cytogenetic AML groups, including favorable, intermediate, and unfavorable categories.
Main Results:
- Downregulated HOX expression characterized favorable AML, with inv(16) cases showing a unique profile.
- A 17-gene predictor achieved 94.7% specificity in classifying favorable versus intermediate/unfavorable AML.
- HOX overexpression was linked to NPM mutations in AML, and HOXA9 levels inversely correlated with survival.
- BMI-1 was overexpressed in MLL-rearranged leukemias, suggesting p19(ARF) suppression involvement.
Conclusions:
- HOX gene expression patterns are closely associated with specific AML subtypes and cytogenetic classifications.
- HOX expression profiling can aid in AML risk stratification and potentially identify therapeutic targets.
- Further research is needed to elucidate the functional role of HOX gene dysregulation in AML pathogenesis.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
02:33Hedgehog Signaling Pathway
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...